Pro Medicus Ltd banner

Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 169.59 AUD 0.58%
Market Cap: AU$17.7B

Wall St Price Targets

PME Price Targets Summary
Pro Medicus Ltd

Wall Street analysts forecast PME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PME is 217.03 AUD with a low forecast of 128.27 AUD and a high forecast of 262.5 AUD.

Lowest Forecast
Price Target
128.27 AUD
24% Downside
Average Forecast
Price Target
217.03 AUD
28% Upside
Highest Forecast
Price Target
262.5 AUD
55% Upside
Pro Medicus Ltd Competitors:
Price Targets
WHF
WhiteHorse Finance Inc
23% Upside
CIM
Chimera Investment Corp
24% Upside
DHI
D R Horton Inc
20% Upside

Revenue
Forecast

25% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
25% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 7 years is 15%.

Gross Profit
Forecast

26% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
26% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 14 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 7 years is 15%.

Operating Income
Forecast

64% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
64% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 14 years, the compound annual growth rate for Operating Income has been 64%. The projected CAGR for the next 7 years is 11%.

Pre-Tax Income
Forecast

53% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
53% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 53%. The projected CAGR for the next 3 years is 4%.

Net Income
Forecast

43% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
43% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 14 years, the compound annual growth rate for Net Income has been 43%. The projected CAGR for the next 7 years is 2%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PME's stock price target?
Price Target
217.03 AUD

According to Wall Street analysts, the average 1-year price target for PME is 217.03 AUD with a low forecast of 128.27 AUD and a high forecast of 262.5 AUD.

What is the Revenue forecast for Pro Medicus Ltd?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 7 years is 15%.

What is the Gross Profit forecast for Pro Medicus Ltd?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 7 years is 15%.

What is the Operating Income forecast for Pro Medicus Ltd?
Projected CAGR
11%

Over the last 14 years, the compound annual growth rate for Operating Income has been 64%. The projected CAGR for the next 7 years is 11%.

What is the Pre-Tax Income forecast for Pro Medicus Ltd?
Projected CAGR
4%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 53%. The projected CAGR for the next 3 years is 4%.

What is the Net Income forecast for Pro Medicus Ltd?
Projected CAGR
2%

Over the last 14 years, the compound annual growth rate for Net Income has been 43%. The projected CAGR for the next 7 years is 2%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett